Author: Aakanksha Gajula
Global pharma businesses are finding India to be an increasingly appealing location for outsourcing services. India is placed fourth worldwide as a possible outsourcing location, per the 11th annual report on Biopharmaceutical Manufacturing Capacity and Production. Although medical outsourcing only accounts for a small portion of India’s burgeoning outsourcing sector, experts claim that it is expanding at a rate of 150% each year and is showing no signs of slowing down. In India, the healthcare BPO industry is still rather small. Currently, the industry is thought to be worth $300 million. But it has a lot of potentials and is a lovely area. Since many jobs can be completed for much less money abroad than they can at home, healthcare providers, insurance firms, pharmaceutical companies, and healthcare IT companies make up the four groups that turn to India for their outsourcing needs. As organizations in the healthcare sector look for ways to reduce excessive healthcare expenses, this trend will only intensify. Since many jobs can be completed for much less money abroad than they can at home, healthcare providers, insurance firms, pharmaceutical companies, and healthcare IT companies make up the four groups that turn to India for their outsourcing needs. As organizations in the healthcare sector look for ways to reduce excessive healthcare expenses, this trend will only intensify.
In the 1990s, India emerged as a popular location for outsourcing in the service industry. By expanding the scope of operations and capacity to handle complexity, outsourcing to India has adapted to the shifting market requirements.
One of the largest sectors of the global economy is healthcare, which until recently trailed behind most other sectors in its use of outsourcing. Health businesses need to develop their ability to provide top-notch patient care as the market grows more competitive. In order to encourage repeat business and recommendations, it is crucial to assure patient happiness. The Patient profile template, however, is a highly unique project that the digital health trend is already prepared to provide the user.
In order to adapt to the new climate, Indian businesses have begun to change their product development procedures. By investigating generic alternatives to copyrighted medications and then pursuing legal action to challenge the patent, the companies have carved out a place for themselves on the world market. The new patent policy has had little impact on this strategy, and it appears to be growing. However, those who can afford it have their sights set on a much higher objective: the discovery of novel molecules. Companies are drawn in by the promise of substantial profit margins and becoming a credible competitor in the global business, notwithstanding the size of the initial expenditure. In an effort to take advantage of these prospects, local businesses have progressively started looking at investing more money in their R&D programs or forming alliances.
Businesses of all sizes may now cut expenses, increase agility, and provide better services thanks to the strategy. In addition to customer service, marketing, human resources, and accounting will all continue to see rise in outsourcing.
The concept of outsourcing is not new; it has been around for more than a thousand years. The only difference is that, for whatever reason, it has recently become much more popular. In essence, outsourcing entails hiring a third-party vendor to perform contractually binding work for you.
Ten greatest advantages of outsourcing
The pharmaceutical business will continue to thrive both internationally and in India. The high disease burden, good growth in personal disposable incomes, improvements in healthcare infrastructure, and improved healthcare funding all support the industry’s outlook for the future. Over the past five years, the Indian pharmaceutical business has expanded at a compound annual growth rate (CAGR) of over 15%.
There are numerous prospects for the sector to flourish. To maintain the strong growth through the year 2020, the pharma enterprises in India will need to reconsider their corporate strategy. To the greatest extent possible, businesses must think creatively and implement new business models. Through partnerships and agreements, Indian pharmaceutical businesses may continue to expand both organically and inorganically.
They need to continually concentrate on raising production and operational effectiveness. By lowering the financial and practical barriers to healthcare access in India, advancements in health insurance, medical technology, and mobile telephony may contribute to the expansion of the pharmaceutical sector.
How useful was this post?
Tasks handled by our staff, updated in real-time.